 CytoDyn Inc has announced the appointment of Dr Seenu Srinivasan as the companys new executive director of chemistry, manufacturing, and controls CMC Regulatory Affairs. Dr Srinivasan, a former director of CMC Regulatory Affairs for Regeneron Pharmaceuticals NASDAQ:REGN Inc, brings 30 years of broad regulatory and drug development experience to his role at CytoDyn, including extensive CMC experience in developing active pharmaceutical ingredients APIs and drug products from early phase to commercialization. 